![]() ![]() Even though all medicines cause side effects, not everyone gets them. Side effects are unwanted symptoms caused by medicines. Take exactly as your health care provider tells you to take it. The Intacept 50mg Injection will be given to you by a health care professional. Do not attempt to inject yourself unless you are trained to do so by your physician or health care provider. Continue using it as recommended by your doctor and complete the dose even if you feel better. You should use it regularly and at the same time each day to get the maximum benefit from it. Intacept 50mg Injection is given by a healthcare professional and should not be self-administered. It provides relief from swelling, pain, and redness associated with various disorders and improves physical function. ![]() The dose should be 0.8 mg/kg (up to maximum of 50 mg per dose) once weekly.Intacept 50mg Injection is a medicine used to treat a variety of conditions such as ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn’s disease. If retreatment of etanercept is indicated, the above guidance on treatment duration should be followed. Treatment should be discontinued in patients who show no response after 12 weeks. Pediatric plaque psoriasis: Children (⩾6 to <18 years): 0.8mg/kg (up to a maximum of 50 mg per dose) once weekly for up to 24 weeks. Intacept has not been studied in children <2 years of age. Glucocoticoids, nonsteroidal anti-inflammatory drugs (NSAIDs), or analgesics may be continued during treatment with etanercept in children. Juvenile idiopathic arthritis: Children (⩾2 to <18 years): 0.4mg/kg (up to maximum of 25 mg per dose) twice weekly (72 to 96 hours apart). ![]() Patients weighing 62.5 kg or more may be fixed-dose prefilled syringe. Patient weighs less than 62.5kg should be accurately dosed on an mg/kg basis. No dose adjustment is required for elderly and or patient with renal and hepatic impairment. With intermittent use, treatment cycles subsequent to the initial cycle should use a dose of 50 mg once weekly. Higher responses may be achieved from initial treatment with a dose of 50 mg twice weekly for up to 12 weeks, followed, if necessary, by a dose of 50 mg once weekly or 25 mg twice weekly.Īdult patients may be treated intermittent or continuously based on physician judgment and individual patient needs. Plaque psoriasis: The dose of etanercept is 50 mg syringe once weekly (as one subcutaneous injection using a 50 mg syringe or as two 25 mg injections given at approximately the same time) or 25 mg twice weekly (72 to 96 hours apart) as a subcutaneous injection. 25 mg once weekly gives a slower response and may be less effective. Methotrexate, glucocorticoids, salicylates, nonsteroidal anti- inflammatory drugs (NSAIDs), or analgesics may be continued during treatment with Intacept in adults. Rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: Patients aged 18 years or older- 50 mg Intacept per week administered either once weekly (as one subcutaneous injection using a 50 mg syringe or as two 25 mg injections given at the same time) or 25 mg Intacept twice weekly (72 to 96 hours apart) as a subcutaneous injection. ![]()
0 Comments
Leave a Reply. |